SCHEMBL23483194

SCHEMBL23483194

CC(=O)OC[C@@H]1OC[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 10/20 0.47
▸ CA12 O43570 9/20 0.47
▸ CA1 P00915 9/20 0.47
▸ CA9 Q16790 7/20 0.47
▸ THRB P10828 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ TSHR P16473 1/20 0.46
▸ NR3C1 P04150 1/20 0.46
▸ FYN P06241 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ ADRA2B P18089 1/20 0.46
▸ DRD4 P21917 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ PKM P14618 1/20 0.41
▸ PTPN1 P18031 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ CA4 P22748 2/20 0.40
▸ CA5A P35218 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17030500 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL18880349 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL16672158 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL1469270 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL24455472 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL4733408 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL23266163 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL24145415 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL20870238 1.00 CA2 (0.47) CA2CA12CA1CA9THRB
SCHEMBL18897548 1.00 CA2 (0.47) CA2CA12CA1CA9THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021113635-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-06-10 — — WO disclosed
Send feedback